PRECIGEN (PGEN) Chief Legal Officer converts 40,443 RSUs into common stock

Rhea-AI Filing Summary

PRECIGEN, INC. Chief Legal Officer Donald P. Lehr reported a compensation-related equity transaction involving restricted stock units (RSUs). On March 18, 2026, he received a grant of 40,443 RSUs, each representing a contingent right to one share of common stock, at a stated price of $0.0000 per unit.

The footnotes state that these RSUs vested immediately on the grant date. On the same date, Lehr exercised the 40,443 RSUs, converting them into 40,443 shares of common stock at an exercise price of $0.0000. Following this exercise, his directly held common stock position increased to 722,092 shares, and no remaining derivative position is shown in this filing.

This sequence reflects an RSU grant and immediate vesting-and-exercise rather than an open-market purchase or sale, making it a routine equity compensation event for a senior executive.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lehr Donald P.

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MARYLAND 20876

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		M		40,443	A	(1)	722,092	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/18/2026		A		40,443		(2)	(2)	Common Stock	40,443	$0	40,443	D
Restricted Stock Units	(1)	03/18/2026		M			40,443	(2)	(2)	Common Stock	40,443	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

2. The RSUs vested immediately upon the grant date.

	/s/ Donald P. Lehr	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PRECIGEN (PGEN) report for Donald P. Lehr?

PRECIGEN reported that Chief Legal Officer Donald P. Lehr received and exercised 40,443 restricted stock units on March 18, 2026. The RSUs converted into 40,443 common shares as part of his equity compensation, rather than through open-market trading.

How many PRECIGEN (PGEN) RSUs were granted to Donald P. Lehr?

Donald P. Lehr was granted 40,443 restricted stock units of PRECIGEN on March 18, 2026. Each RSU represents a contingent right to receive one share of common stock, reflecting a standard equity award for a senior executive officer.

Did the PRECIGEN (PGEN) RSUs granted to Donald P. Lehr vest immediately?

Yes, the filing states that the RSUs vested immediately on the grant date. This immediate vesting allowed Lehr to exercise all 40,443 RSUs on the same day and receive an equal number of PRECIGEN common shares without a cash exercise price.

What is Donald P. Lehr’s PRECIGEN (PGEN) common stock holding after this Form 4?

After exercising 40,443 RSUs, Donald P. Lehr directly holds 722,092 shares of PRECIGEN common stock. This total reflects his position following the reported RSU grant and conversion, with no remaining RSU derivative position shown in this particular filing.

Was there any open-market buying or selling in this PRECIGEN (PGEN) Form 4?

No, the transactions involve RSU grant and exercise at a price of $0.0000 per unit, not open-market buying or selling. The Form 4 codes show an award (A) and derivative exercises (M), typical of routine equity compensation activity for executives.

What do the Form 4 codes A and M mean in the PRECIGEN (PGEN) filing?

Code A indicates a grant or award of derivative securities, here 40,443 RSUs. Code M indicates the exercise or conversion of a derivative, reflecting the RSUs being converted into 40,443 common shares with a stated price of $0.0000.